| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.096 | 0.09 |